Literature DB >> 31335662

Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients: Erratum.

.   

Abstract

Entities:  

Year:  2019        PMID： 31335662      PMCID： PMC7144746          DOI： 10.1097/j.pain.0000000000001645

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   7.926


× No keyword cloud information.
  1 in total

1.  Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients.

Authors:  Jitsu Kato; Norimitsu Matsui; Yoshihiro Kakehi; Emiko Murayama; Shoichi Ohwada; Masahiro Sugihara
Journal:  Pain       Date:  2019-05       Impact factor: 7.926
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.